CY Oriental Holdings

CY Oriental Holdings is a specialty pharmaceutical company and a key subsidiary of China Medical System Holdings (CMS), a leading pharmaceutical service provider in China. The company specializes in the acquisition, marketing, and distribution of international pharmaceutical brands within the Chinese healthcare market, focusing on therapeutic areas such as gastroenterology, psychiatry, and hepatology. CY Oriental holds the exclusive rights to several well-known products, including Deanxit for the treatment of depression and anxiety, and Salofalk for inflammatory bowel diseases. Following its full acquisition by CMS in 2014, the company has been integrated into the parent's extensive nationwide sales and promotion network. Its business model centers on bridging the gap between global pharmaceutical manufacturers and the growing demand for specialized treatments in China.